← Back to Search

A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System (CATALYSTEM Trial)

N/A
Waitlist Available
Research Sponsored by Smith & Nephew, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up preoperative, 6-weeks, 1-year, 2-years and 5 years post-operative
Awards & highlights
No Placebo-Only Group

Summary

A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.

Eligible Conditions
  • Arthritis
  • Osteoarthritis
  • Avascular Necrosis
  • Rheumatoid Arthritis
  • Congenital Hip Dysplasia
  • Total Hip Replacement

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~preoperative, 6-weeks, 1-year, 2-years and 5 years post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and preoperative, 6-weeks, 1-year, 2-years and 5 years post-operative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CATALYSTEM™ femoral stem implant survivorship 2 years post-operatively by stem type (collared/collarless)
Secondary study objectives
CATALYSTEM™ femoral stem implant survivorship rates by stem type (collard/collarless)
EuroQol 5-Dimension 5-Level Visual Analogue Scale (EQ-5D-5L VAS)
Hip Disability and Osteoarthritis Outcome Score, Junior (HOOS Jr)
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CATALYSTEMExperimental Treatment1 Intervention
Participants who have already received or are due to receive the CATALYSTEM Cementless Primary Hip System

Find a Location

Who is running the clinical trial?

Smith & Nephew, Inc.Lead Sponsor
169 Previous Clinical Trials
22,310 Total Patients Enrolled
32 Trials studying Osteoarthritis
4,427 Patients Enrolled for Osteoarthritis
Rachel JahnkeStudy DirectorSmith & Nephew, Inc.
1 Previous Clinical Trials
140 Total Patients Enrolled
~132 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top